PT - JOURNAL ARTICLE AU - Stephens, Christopher R. AU - González-Salazar, Constantino AU - Martínez, Pedro Romero TI - “Does a respiratory virus have an ecological niche, and if so, can it be mapped?” Yes and yes AID - 10.1101/2022.05.04.22274675 DP - 2022 Jan 01 TA - medRxiv PG - 2022.05.04.22274675 4099 - http://medrxiv.org/content/early/2022/05/07/2022.05.04.22274675.short 4100 - http://medrxiv.org/content/early/2022/05/07/2022.05.04.22274675.full AB - Although the utility of Ecological Niche models (ENM) and Species Distribution models (SDM) has been demonstrated in many ecological applications, their suitability for modelling epidemics or pandemics, such as SARS-Cov-2, has been questioned. In this paper, contrary to this viewpoint, we show that ENMs and SDMs can be created that can describe the evolution of pandemics, both in space and time. As an illustrative use case, we create models for predicting confirmed cases of COVID-19, viewed as our target “species”, in Mexico through 2020 and 2021, showing that the models are predictive in both space and time. In order to achieve this, we extend a recently developed Bayesian framework for niche modelling, to include: i) dynamic, non-equilibrium “species” distributions; ii) a wider set of habitat variables, including behavioural, socio-economic and socio-demographic variables, as well as standard climatic variables; iii) distinct models and associated niches for different species characteristics, showing how the niche, as deduced through presence-absence data, can differ from that deduced from abundance data. We show that the niche associated with those places with the highest abundance of cases has been highly conserved throughout the pandemic, while the inferred niche associated with presence of cases has been changing. Finally, we show how causal chains can be inferred and confounding identified by showing that behavioural and social factors are much more predictive than climate and that, further, the latter is confounded by the former.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by DGAPA-PAPIIT special project grant IV100520: EpI-PUMA: Una Plataforma Universitaria de Inteligencia Epidemiologica de SARS-Cov-2Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study uses ONLY openly available data from the Direccion General de Epidemiology of the Secretaria de Salud Mexico. It is available at: https://www.gob.mx/salud/documentos/datos-abiertos-152127I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. Epidemiological (confirmed cases of COVID-19) data is available at: https://www.gob.mx/salud/documentos/datos-abiertos-152127 https://www.gob.mx/salud/documentos/datos-abiertos-152127